Panther Life Sciences uses a patented microarray patch (MAP) and software-enabled engineering to deliver shelf-stable skin treatments directly to consumers worldwide. Treatments are loaded onto the MAP patch and applied to the skin to release doses, with shelf-stable formulations allowing global distribution as part of an end-to-end platform. Its MAP technology and platform differentiate it by enabling partnerships across skincare, pharma, biotech, and other industries, not just a single product. The goal is to reshape healthcare by making skin-based treatments easier to access globally and by providing a versatile platform for collaboration and delivery.
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2023
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
Hybrid Work Options
Company Equity
Panther Life Sciences appoints Mounir Hanana as Chief Executive Officer. Hanana joins as Panther begins commercializing its SmartPatch(TM) platform, starting with cosmetics & medical aesthetics and expanding to therapeutic applications. Its team has built a unique, powerful technology capable of transforming both consumer and medical markets." - Mounir Hanana, CEO of Panther Life Sciences NEW YORK, NY, UNITED STATES, September 9, 2026 /EINPresswire.com/ - Panther Life Sciences today announced the appointment of Marcus "Mounir" Hanana as Chief Executive Officer. Founder Carlos Bhola will continue as Executive Chairman, partnering closely with Hanana as Panther commercializes its SmartPatch(TM) platform across high-growth health, wellness and therapeutic markets, including dermatology and aesthetic applications. "Beginning in late 2023 with a small, agile team, we combined innovations in skin biology with advanced engineering expertise to develop a delivery platform for next-generation treatments. We are now ready to deploy our SmartPatch, in 2027, which requires go-to-market and commercialization capabilities," said Bhola. "We were intentional in our search for a partner with a track record of deploying global technology platforms, scaling manufacturing, and commercializing innovation - and we found that in Mounir. I am excited by what Panther will accomplish under Mounir's direction and am looking forward to closely partnering with him." Hanana brings 25 years of global leadership experience across Procter & Gamble and Amazon. During his career, he has led initiatives ranging from several hundred million dollars in revenue to large global multibillion-dollar businesses, combining expertise in manufacturing, commercialization, technology platforms and operational scale. At Procter & Gamble, he helped bring consumer products from development to market through world-class manufacturing, supply chains and commercial organizations. At Amazon, he led large global technology businesses, most recently serving as CFO of Amazon Business, one of the company's fastest-growing global businesses. Together, these experiences span consumer products, advanced manufacturing, global technology platforms and operational excellence - capabilities critical for Panther's next phase of commercialization. "Having spent much of my career building and scaling global businesses, I know a category-defining opportunity when I see one," said Hanana. "That is why I joined Panther. Our team has built a unique, powerful technology capable of transforming both consumer and medical markets. I am looking forward to partnering with Carlos as we build the operational foundation to bring this platform to consumers at scale." With Hanana leading Panther's operations, commercialization and organizational growth, Bhola will focus on leading strategy, product vision and corporate development. About Panther Life Sciences Panther Life Sciences is building the leading skin-powered delivery platform for health, wellness and therapeutics. Its proprietary intradermal SmartPatch(TM) precisely delivers treatments through the skin, unlocking the skin as a scalable gateway for care. Panther's AI-based platform accelerates product development and personalizes treatment and care, resulting in compelling provider and consumer experiences. Panther is led by a team of successful entrepreneurs and operators and is advised by leading scientific experts. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Today in New York do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Biomanufacturing and partnerships drive innovation in Greater Hazelwood. Jun 2, 2026 Biomanufacturing, workforce development, and community partnerships are shaping the future of Greater Hazelwood, a neighborhood along the Monongahela River where a former brownfield is being transformed into a sustainability, research, and innovation tech hub, according to a June 2 report. At an event in late April, Heidi Ward, who leads the University of Pittsburgh's Greater Hazelwood Neighborhood Commitment; Ian Johnson, director of life sciences at BioForge; and Rosta Farzan, associate dean for Engaged Scholarship at Pitt's School of Computing and Information Sciences, discussed efforts to connect neighborhood priorities with opportunities in the life sciences sector. The event was part of the Pitt Alumni Association's Pitt Academy speaker series. Vice Chancellor for External Relations Lina Dostillio said, "The Plan for Pitt 2028 calls for us to be a University that is welcoming and engaged, place-based, committed to the communities of Western Pennsylvania and striving to have a positive effect on the world around us. We are a partner in solving the real problems that folks are facing. It means we are showing up every day to expand workforce development opportunities, and our research is opening new doors. We are an economic anchor, as well." The discussion took place at the restored Roundhouse - a former J&L Steel mill facility now serving as coworking space - highlighting how investment has shifted from industrial steel production toward technology-driven innovation at Hazelwood Green. Ward described this transformation: "This building is a metaphor for what's possible when research, industry and neighborhood partnerships all work together to shape Pittsburgh's next chapter." Johnson detailed BioForge's role in helping researchers and startups address manufacturing challenges. He explained that BioForge partners with academic innovators on projects such as Furnace - an mRNA brokerage platform - and microneedle patch technology developed by Pitt-connected researchers. Johnson also noted that Panther Life Sciences relocated operations to Pittsburgh after working with BioForge. Ward highlighted more than 25 years of collaboration between Pitt and Greater Hazelwood but said recent developments prompted questions about ensuring local residents benefit from new innovations. In response, Pitt launched initiatives including middle school biotechnology activities and public science events as well as piloting a Life Sciences Bridge Program - a paid workforce development initiative introducing young adults without college degrees to careers in biotechnology. Farzan discussed community engagement efforts involving local organizations like Center of Life and Hazelwood Initiative. One project focused on air quality monitoring with resident participation guiding sensor placement while students assisted with data collection. Farzan said successful collaboration requires patience: "That is actually how we learn a lot about how to best solve these problems and build technologies that are actually better for everyone." The panel emphasized that progress depends on long-term relationships built through trust between institutions like Pitt and neighborhood residents.
Partnership to Deliver More Effective Treatments for Skin-Based and Immune-Mediated Applications
Panther Life Sciences partners with BioForge to accelerate development and manufacturing of microarray patches.